• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Cell-based Cytokine Delivery strategy for chroniccerebral infarction

Research Project

Project/Area Number 24659660
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Cerebral neurosurgery
Research Institution公益財団法人先端医療振興財団

Principal Investigator

MATSUYAMA Akifumi  公益財団法人先端医療振興財団, 再生医療開発支援部, 部長 (10423170)

Co-Investigator(Kenkyū-buntansha) TAGUCHI Akihiko  (公財)先端医療振興財団, 再生医療研究部, 部長 (10359276)
Project Period (FY) 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Keywords再生医学 / 脳血管障害学
Research Abstract

INTRODUCTION: Stem cell therapy can promote good recovery from stroke. Several studies have demonstrated that adipose tissue-derived cells are safe and effective. However, more infbrmation regarding appropriate cell type is needed from animal model. This stUdy was targeted at analyzing the effects in ischemic stroke ofintravenous(i.v.)administration ofadipose tissue-derived multi-lineage progenitor cells(ADMPCs)and adipose-derived-stem cells(ADSCs)on fUnctional evaluation results. METHODS:ADMPCs or ADSCswere administered intravenously 30 minutes after permanent middle cerebral artery occlusion(pMCAO)to rats. Infarct volume was analyzed by histologically. Function was evaluated by the Rogers and rotarod tests. RESULTS:Compared to infarct group, fUnction had significantly improved after i.v. administration of ADMPCs but not ADSCs. Reduction in infarct volume was observed in the ADMPC-transplanted group nut not in the ADSC-one. CONCLUSIONS: i.v. administration ofADMPCs but not AD SCs, in pMCAO infarct was associated with good fUnctional recovery, and reductions in infarct volume.

Report

(2 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • Research Products

    (8 results)

All 2012 2011 2010

All Journal Article (7 results) (of which Peer Reviewed: 7 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Adipose Tissue-Derived Multi-lineage Progenitor Cells as a Prom ising Tool for 1カSitu Stem Cell Therapy2012

    • Author(s)
      Okura H, Saga A, Soeda M. Ichinose A, Matsuyama A
    • Journal Title

      Current Tissue Engineering

      Volume: (In press)

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Tissue engineered myoblast sheets improved cardiac function sufHciently to discontinue LVAS in a patient with DCM: report of a case2012

    • Author(s)
      Sawa Y, Miyagawa S, Sakaguchi T, Fuj ita T, .Matsuyama A, Saito A, Shimizu T, Okano T
    • Journal Title

      Surg Today

      Volume: 42 Pages: 181-184

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Patients with CD36 Deficiency Are Associated with Enhanced Atherosclerotic Cardiovascular Diseases2011

    • Author(s)
      Yuasa-Kawase M, Masuda D, Yamashita T, Kawase R, Nakaoka H, Inagaki M, Nakatani K, Tsubakio-Yamamoto K, Ohama T, .Matsuyama A, Nishida M, Ishigami M, Kawamoto T, Komuro I, Yamashita S
    • Journal Title

      J Atheroscler Thromb

      Volume: 19 Pages: 263-275

    • NAID

      130004444587

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Fasting Serum Apolipoprotein B-48 Can be a Marker of Postprandial Hyperlipidemia2011

    • Author(s)
      Masuda D, Sakai N, Sugimoto T, Kitazume-Taneike R, Yamashita T, Kawase R,Nakaoka H, Inagaki M, Nakatani K, Yuasa-Kawase M, Tsubakio-Yamamoto K, Ohama T, Nakagawa-Toyama Y, Nishida M, Ishigami M, Masuda Y, Matsuyama A, Komuro I, Yamashita S
    • Journal Title

      J Atheroscler Thromb

      Volume: 18 Pages: 1062-1070

    • NAID

      130004845356

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Reduction of Neu5GC Xenoantigen on Human ADMSCs lead to Them as Safer and More Useful Cell Sources fbr Realizing Various Stem Cell Therapies2010

    • Author(s)
      Komoda H, Okura H, LeeC-M, Sougawa N, Iwayama T, Hashikawa T, Saga A, Yamamoto-Kakuta A, Ichino se A, Murakami S, Sawa Y and Matsuyama A
    • Journal Title

      Tissue Eng Part A

      Volume: 16(4) Pages: 1143-1155

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins2010

    • Author(s)
      Okura H, Yamashita S, Tohru Ohama, Saga A,Kakuta-Yamamoto A, Hamada Y, Ohyama R, Sawa Y and Matsuyama A
    • Journal Title

      J Atheroscler Thromb

      Volume: 17(6) Pages: 568-577

    • NAID

      130004845317

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfUnction and survival in a rat myocardial infarction model2010

    • Author(s)
      Okura H, Matsuvama A. Lee CM, Saga A, Kakuta-Yamamoto A, Nagao A, Sougawa N,Sekiya N, Takekita K, Shudo Y, Miyagawa S, Komoda H, Okano T, Sawa Y
    • Journal Title

      Tissue Eng Part C Methods

      Volume: 16(3) Pages: 417-425

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Patent(Industrial Property Rights)] 心筋指向性細胞を含む細胞製剤2012

    • Inventor(s)
      松山晃文、大倉華雪
    • Industrial Property Rights Holder
      理化学研究所、大阪大学、(公財)先端医療振興財団
    • Industrial Property Number
      2012-100362
    • Filing Date
      2012-04-25
    • Related Report
      2012 Final Research Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi